HomeALLR • NASDAQ
add
Allarity Therapeutics Inc
Previous close
$1.14
Day range
$1.10 - $1.16
Year range
$0.61 - $2.35
Market cap
17.59M USD
Avg Volume
207.82K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.52M | -3.52% |
Net income | -2.81M | 75.79% |
Net profit margin | — | — |
Earnings per share | -0.19 | 89.13% |
EBITDA | -2.51M | 3.80% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 16.90M | -8.49% |
Total assets | 20.80M | 2.05% |
Total liabilities | 8.78M | 18.49% |
Total equity | 12.01M | — |
Shares outstanding | 15.81M | — |
Price to book | 1.52 | — |
Return on assets | -29.98% | — |
Return on capital | -46.73% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -2.81M | 75.79% |
Cash from operations | -3.41M | 37.35% |
Cash from investing | — | — |
Cash from financing | 2.31M | -52.55% |
Net change in cash | -906.00K | -17.66% |
Free cash flow | -2.28M | 51.33% |
About
Founded
2004
Headquarters
Website
Employees
6
